Business Standard

Serum Institute to make 100 mn more doses of Covid vaccine for Rs 250 each

Secures additional $150 mn risk funding from Bill and Melinda Gates Foundation

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
Pune-based Serum Institute of India (SII), the world’s largest vaccine maker by volume, will now be producing an additional 100 million Covid-19 vaccine doses for India as well as low- and medium-income countries (LMICs) in 2021. The vaccine will come for $3 or around Rs 250 per dose.
 
This would take the total volume of vaccines that SII will offer at this price to 200 million. The company has received an additional $150 million risk funding from the Bill and Melinda Gates Foundation. The announcement practically takes forward the collaboration among SII, Gavi, the Vaccine Alliance and Bill and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 29 2020 | 4:17 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com